headerbild

29. January 2020

TIVTA® appears once again in the lead topic of a major magazine.

After the lead topic in “The Oncologist”, there will be a second lead topic in January 2020, in which our TIVITA® will be the subject of discussion. An article by the Clinic and Polyclinic for Oral and Maxillofacial Surgery – Plastic Surgery of the University Medical Center Mainz entitled “Digitalization and approaches of artificial intelligence in microvascular-reconstructive facial surgery” was recently published in “Der Chirurg”.
We are very pleased about the increasing presence of our innovative tissue camera for contactless detection of perfusion disorders in various medical disciplines.
Many thanks to the working group around Dr. Peer Kämmerer for the use of our TIVITA® and for the announcement.

Click here for the article.

23. January 2020

New publication about the increasing importance of intraoperative imaging and visualization released

We are very pleased about the latest publication (managed by the German Cancer Research Center) of Prof. Maier-Hein in Heidelberg, which was published as a lead topic in “The Oncologist”.

It deals with the growing importance of computer assistance during surgical procedures and especially with intraoperative visualization. While the use of intraoperative visualization was previously mostly limited to preoperative planning, it is now increasingly used for intraoperative decision-making and support with the aim of improving precision and thus the results. Above all, real-time intraoperative data acquisition and information processing play a more and more important role. Based on images taken with our TIVITA®, HSI imaging is very well illustrated in this article.

This shows once again that we are on the right track with our products and we will keep working hard to establish spectral imaging as a standard technology in surgery.
At the same time, more and more studies show that the complication rates during surgery can be significantly reduced by the intraoperative use of perfusion imaging methods.

Click here for the article.

14. January 2020

Our new office building is completed!

At the beginning of the new year we could finally move into our new office building, the “Kegelrobbe”. It is located at Strandstraße 14, right next to the main building “Seehund” and accommodates all administrative staff of Diaspective Vision. We now have a bright and airy meeting room, which can be reached at ground level, and an extra room for Skype conversations.

The emptied rooms on the ground floor of the “Seehund” will be used for our production in the future.
We are very happy that the limited space is a thing of the past and that there is still enough space left for new employees!

Start of the year 2020

First of all, we would like to wish everyone a happy, successful but above all healthy year 2020.
An exciting year lies ahead of us, which seems to be no less turbulent than the past one.
Right at the beginning of 2020, we received the publication “Indocyanine green fluorescence imaging to reduce the risk of anastomotic leakage in laparoscopic low anterior resection for rectal cancer: a propensity score-matched cohort study” by Jun Watanabe, which shows in more than 500 patients that the rate of insufficiency is reduced by at least half when the ideal border zone is determined with ICG.

This prompts us to once again point out the great work done in Leipzig around Professor Gockel.
Among other things, a comparative study of ICG and HSI is currently being carried out, in which both technologies are to be used to demonstrate the usefulness of objective boundary zone definition. Already in previous publications it could be proven that HSI is able to do so ( for example in: Jansen-Winkeln B, Holfert N, Köhler H., Chalopin C, Gockel I (2019): Determining the ideal anastomosis position by hyperspectral imaging. In: Journal of Gastroenterology 2019; 57(09): p. 219; DOI: 10.1055/s-0039-1695193).

Prof. Gockel also organizes an annual surgical workshop on the topic of “Hyperspectral Imaging in Visceral Surgery”. This year the event will take place on 15.05.2020 at the University Hospital Leipzig. We kindly invite you to participate. Please find the flyer of the event >here.

All the best for the new year!
Be Diaspectivisionary and have a good time!

14. October 2019

Augmented HSI presented and awarded

A novel approach for HSI in medicine has been presented at the 27th “International EAES Congress” in Sevilla-Spain. The technology called “augmented hyperspectral imaging” (AHSI) combines the false-color images of the TIVITA with the use of additional dyes to generate even more information of the tissue.
In “Augmented Hyperspectral Imaging: A modified technology for the evaluation of tissue perfusion and integrity”
the Alexander Studier-Fischer and his team presented their technology and evaluation methods.
“Visualization of induced reversible and persistent jejunal ischemia through hyperspectral imaging” showed the resukts of AHSI in a porcine model to visualize jejunal ishemia. They also compared the outcome of AHSI to regular investigation by eye and also to ICG fluorescence imaging.
The latter one has been awarded as one of the best presentations of the “Gerhard Buess Technology Award Session”. We kindly congratulate Mr. Alexander-Fischer on this great work.

26. August 2019

New publication about the potential of HSI released

The week started for us with the good news of the latest publication from Leipzig which was published in “Der Chirurg”. It deals with the many applications and opportunities for TIVITA® in the surgical field. We are happy about the great scientific support we receive from Leipzig day-to-day and which this article provides a good overview of.
A big thank you to the team from Leipzig!
You can find the publication under the Link.

01. August 2019

BMBF funding granted

Tissue ablation by laser is a common method for tumor resection, especially for endoscopic procedures. However, the recognition of the tumor margins is a major problem because during the operation, there is no time to carry out an extensive histological examination. This leads to repeated operations and a lower recovery potential for the patients.

Some time ago, the potential of hyperspectral imaging (HSI) for the detection of tumor tissue was recognized. As a result, the joint project “TheraOptik” was launched. The aim of this project is the development of a combined solution consisting of endoscope, ablation laser and HSI imaging, which enables the real-time detection of remaining tumor tissue and thus maximizes the chances of successful treatment.
Today, the funding by the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung – BMBF) for “TheraOptik” was confirmed.

We are very pleased with the provided funds, which will enable us to begin work immediately in order to improve cancer treatment in the near future.

18. July 2019

“HYPerspectral Enhanced Reality” in the journal “Surgical Endoscopy”

The future of HSI?!

The team of the IRCAD Strasbourg published their work “HYPerspectral Enhanced Reality (HYPER): a physiology-based surgical guidance tool.”

The extensive article in the journal “Surgical Endoscopy” deals with the use of hyperspectral imaging (HSI) for detection and quantification of ischemia of intestinal tissue. Focusing on clinical application, the collected HSI data was transferred to an augmented reality environment. To achieve this, an algorithm was trained and its reliability was tested. Thus a tangible, practical solution is presented to display perfusion parameters in the live image of a video.

Furthermore, Barberio et al. showed that the parameters StO2, NIR perfusion and Tissue Water Index (TWI) correlate with biomarkers such as local capillary lactate (LCL) and oxygen radicals (ROS).

We kindly congratulate Dr. Barberio and his team on this seminal article and are looking forward to their future work.

08. July 2019

TIVITA®at high-altitude flight

Our cooperation partner HAIP wants to make agriculture more efficient in order to save costs and reduce environmental pollution. For this purpose, problems should be identified earlier and dealt with more specifically.

One component is the optical analysis of the fields from the air, which is carried out with the help of our TIVITA®. The drone’s maiden flight recently took place.
HAIP can be found here

We keep our fingers crossed for HAIP for the upcoming tasks and look forward to a further cooperation!

12. June 2019

Diaspective Vision and endoscopy specialist KARL STORZ sign technology partnership agreement

Pepelow, 12.06.2019: As a result of its experience in hyperspectral imaging – an innovative and promising diagnostic technology for medicine – Diaspective Vision GmbH has succeeded in acquiring the renowned medical technology company KARL STORZ SE & Co. KG (Tuttlingen/Germany) for a technology partnership.

KARL STORZ, the medical technology company specialized in endoscopy, will expand its product portfolio in the field of non-invasive and contrast medium-free imaging procedures with Hyperspectral Imaging (HSI) systems and intends to use these as a suitable complement to endoscopic imaging systems.

For Diaspective Vision, this cooperation represents a great success and a promising milestone in the company’s development. KARL STORZ is not only a strong partner with many years of medical technology expertise for the coming challenges, but this cooperation also offers an optimal platform for establishing the process with physicians worldwide. “This partnership is possible because our highly specialized team is continuously working on the further development of diagnostic solutions. Within the first few weeks, it already became apparent how many synergies can be created in the joint cooperation”, explains Dr. Axel Kulcke, Managing Director of Diaspective Vision. “I am pleased to see that our team has succeeded in setting this strong signal for our company and our region,” he continues.

The next steps are already being prepared in order to make medical diagnostics even better in other fields of application and with increased objectivity in the future, whereby the focus is always on optimized patient care.

About the companies:
KARLS STORZ SE & Co. KG is the leading manufacturer in endoscopy and offers solutions for human and veterinary medicine. For more than 70 years, the family-run company from Baden-Wuerttemberg has stood for tradition, high-tech and quality.

Diaspective Vision GmbH is an innovative medical technology company based in Mecklenburg-Western Pomerania, which was founded in 2015 to establish hyperspectral imaging technology in medicine.